NCT05925829View on ClinicalTrials.gov

Stromal Vascular Fraction and Autologous Activated Platelet-Rich Plasma Combination in Treating Treatment of Type 2 Diabetes

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

December 1, 2017

Study Completion Date

December 1, 2017

Conditions
Diabetes Mellitus, Type 2Platelet-rich PlasmaStromal Vascular Fraction
Interventions
BIOLOGICAL

SVF and aaPRP

Stromal vascular fraction and autologous activated platelet-rich plasma

Trial Locations (1)

10430

Hayandra Peduli Foundation, Jakarta Pusat

All Listed Sponsors
lead

Hayandra Peduli Foundation

OTHER

NCT05925829 - Stromal Vascular Fraction and Autologous Activated Platelet-Rich Plasma Combination in Treating Treatment of Type 2 Diabetes | Biotech Hunter | Biotech Hunter